WINNERS & LOSERS: Pharma in the red; DCC jumps after takeover approach
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday. Read More
| Price | 379.40p on 14-05-2026 at 07:55:17 |
|---|---|
| Change | 4.60p 1.23% |
| Buy | 379.60p |
| Sell | 379.00p |
| Last Trade: | Buy 20.00 at 379.325p |
| Day's Volume: | 177,606 |
| Last Close: | 374.80p |
| Open: | 376.20p |
| ISIN: | GB00BP92CJ43 |
| Day's Range | 373.80p - 379.40p |
| 52wk Range: | 320.00p - 610.00p |
| Market Capitalisation: | £1.68b |
| VWAP: | 377.88796p |
| Shares in Issue: | 441.68m |
Tate & Lyle (TATE) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 20 | 379.325p | Suspected BUY Trade |
08:55:10 - 14-May-26 |
| Unknown* | 0 | 379.00p | SI Trade |
08:54:49 - 14-May-26 |
| Unknown* | 0 | 379.20p | SI Trade |
08:54:49 - 14-May-26 |
| Buy* | 158 | 379.40p | Automatic Execution |
08:54:49 - 14-May-26 |
| Buy* | 264 | 379.20p | Automatic Execution |
08:54:49 - 14-May-26 |
| Buy* | 2,857 | 379.20p | Automatic Execution |
08:54:49 - 14-May-26 |
| Buy* | 81 | 379.00p | Automatic Execution |
08:54:49 - 14-May-26 |
| Sell* | 5,000 | 379.00p | Automatic Execution |
08:54:49 - 14-May-26 |
| Sell* | 53 | 379.00p | Automatic Execution |
08:54:49 - 14-May-26 |
| Sell* | 580 | 379.00p | Automatic Execution |
08:54:49 - 14-May-26 |
Tate & Lyle (TATE) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st May 2026 10:00 am | RNS | Total Voting Rights |
| 1st Apr 2026 4:00 pm | RNS | Holding(s) in Company |
| 27th Mar 2026 2:00 pm | RNS | Holding(s) in Company |
| 13th Mar 2026 4:00 pm | RNS | Holding(s) in Company |
| 2nd Mar 2026 2:00 pm | RNS | Holding(s) in Company |
| 26th Feb 2026 7:00 am | RNS | Trading Statement |
| 23rd Feb 2026 10:00 am | RNS | Holding(s) in Company |
| 17th Feb 2026 12:00 pm | RNS | Holding(s) in Company |
| 21st Jan 2026 7:00 am | RNS | Directorate change |
| 15th Jan 2026 9:00 am | RNS | Holding(s) in Company |